Predictors of Anticoagulation Control on Warfarin Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00905177 |
Recruitment Status
:
Completed
First Posted
: May 20, 2009
Last Update Posted
: May 20, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Atrial Fibrillation Deep Vein Thrombosis Heart Valve Replacement |
Study Type : | Observational |
Actual Enrollment : | 687 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Predictors of Anticoagulation Control on Warfarin Therapy |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All Caucasians and African Americans who are new to warfarin therapy
Exclusion Criteria:
- Under 21 years of age
- Non caucasian
- Non african american
- Have an abnormal INR before warfarin or heparin therapy
- Unable to provide consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00905177
United States, Pennsylvania | |
Hospital of the University of Pennsylvania, Anticoagulation Management Center | |
Philadelphia, Pennsylvania, United States, 19104 | |
Philadelphia Veteran Affairs Medical Center | |
Philadelphia, Pennsylvania, United States, 19104 |
Principal Investigator: | Stephen E. Kimmel, M.D. MS | University of Pennsylvania |
Responsible Party: | University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT00905177 History of Changes |
Other Study ID Numbers: |
700902 |
First Posted: | May 20, 2009 Key Record Dates |
Last Update Posted: | May 20, 2016 |
Last Verified: | May 2016 |
Keywords provided by University of Pennsylvania:
Atrial Fibrillation deep vein thrombosis anticoagulation warfarin coumadin |
Additional relevant MeSH terms:
Atrial Fibrillation Thrombosis Venous Thrombosis Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases |
Pathologic Processes Embolism and Thrombosis Vascular Diseases Warfarin Anticoagulants |